ID

27542

Beschrijving

Study Part: Investigator’s Statement Follow-Up. An open-label, up-titration study to assess the dose proportionality of ropinirole controlled release (CR) and to demonstrate the bioequivalence of ropinirole CR (1 x 8 mg) compared to the ropinirole CR (4 x 2 mg) in Parkinson's Disease patients not receiving other dopaminergic therapies. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Phase: phase 2. Study Recruitment Status: Completed. Generic Name: ropinirole. Trade Name: Modutab, ZIPEREVE, ZEPREVE, REPREVE, ADARTREL, REQUIP,Zygara. Study Indication: Parkinson Disease. Study ID: 101468/165. Clinical Study ID: 101468/165

Trefwoorden

Versies (1)
  1. 20-11-17 20-11-17 -
Houder van rechten

GlaxoSmithKline

Geüploaded op

20 november 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Investigator’s Statement Follow-Up Ropinirole Parkinson Disease 101468/165

Engels

Investigator’s Statement Follow-Up

1 Formulieren  
INVESTIGATOR’S STATEMENT
Beschrijving

INVESTIGATOR’S STATEMENT

Alias
UMLS CUI-1
C0008961
UMLS CUI-2
C1710187
Patient Number
Beschrijving

Patient Number

Datatype

text

Alias
UMLS CUI [1]
C1830427
Centre Number
Beschrijving

Centre Number

Datatype

text

Alias
UMLS CUI [1,1]
C0600091
UMLS CUI [1,2]
C0019994
Check all Adverse Event forms are up to date and complete
Beschrijving

Adverse Event

Datatype

boolean

Alias
UMLS CUI [1]
C0877248
Check that the Concomitant Medication form is up to date
Beschrijving

Concomitant Medication

Datatype

boolean

Alias
UMLS CUI [1]
C2347852
Check that all appropriate pages are signed (thus indicating completion) and dated
Beschrijving

consent

Datatype

boolean

Alias
UMLS CUI [1]
C1511481
Check that laboratory results are included
Beschrijving

laboratory results

Datatype

boolean

Alias
UMLS CUI [1]
C1254595
I certify that the observations and findings are recorded correctly and completely in this CRF.
Beschrijving

complete

Datatype

boolean

Alias
UMLS CUI [1]
C0205197
Investigator:
Beschrijving

Investigator

Datatype

text

Alias
UMLS CUI [1]
C2826892
Date:
Beschrijving

Date

Datatype

date

Alias
UMLS CUI [1]
C0011008
Terug naar het begin van de pagina

Similar models

Investigator’s Statement Follow-Up

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
INVESTIGATOR’S STATEMENT
C0008961 (UMLS CUI-1)
C1710187 (UMLS CUI-2)
Patient Number
Item
Patient Number
text
C1830427 (UMLS CUI [1])
Centre Number
Item
Centre Number
text
C0600091 (UMLS CUI [1,1])
C0019994 (UMLS CUI [1,2])
Adverse Event
Item
Check all Adverse Event forms are up to date and complete
boolean
C0877248 (UMLS CUI [1])
Concomitant Medication
Item
Check that the Concomitant Medication form is up to date
boolean
C2347852 (UMLS CUI [1])
consent
Item
Check that all appropriate pages are signed (thus indicating completion) and dated
boolean
C1511481 (UMLS CUI [1])
laboratory results
Item
Check that laboratory results are included
boolean
C1254595 (UMLS CUI [1])
complete
Item
I certify that the observations and findings are recorded correctly and completely in this CRF.
boolean
C0205197 (UMLS CUI [1])
Investigator
Item
Investigator:
text
C2826892 (UMLS CUI [1])
Date
Item
Date:
date
C0011008 (UMLS CUI [1])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial